Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Quest Diagnostics, Inc. (NYSE: DGX) closed at $149.01 up 0.15% from its previous closing price of $148.78. In other words, the price has increased by $0.15 from its previous closing price. On the day, 0.54 million shares were traded. DGX stock price reached its highest trading level at $149.91 during the session, while it also had its lowest trading level at $148.13.
Ratios:
For a deeper understanding of Quest Diagnostics, Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 61.21 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.96. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.65.
On July 10, 2024, Citigroup Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $145 to $165.
On February 26, 2024, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $135.Leerink Partners initiated its Market Perform rating on February 26, 2024, with a $135 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 29 ’24 when PREVOZNIK MICHAEL E sold 32,551 shares for $154.97 per share. The transaction valued at 5,044,516 led to the insider holds 38,478 shares of the business.
KUPPUSAMY KARTHIK sold 1,990 shares of DGX for $304,990 on Aug 28 ’24. The SVP, Clinical Solutions now owns 11,459 shares after completing the transaction at $153.26 per share. On Aug 29 ’24, another insider, PREVOZNIK MICHAEL E, who serves as the Officer of the company, bought 32,551 shares for $154.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DGX now has a Market Capitalization of 16587345920 and an Enterprise Value of 21522376704. As of this moment, Quest’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.10, and their Forward P/E ratio for the next fiscal year is 15.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.77 while its Price-to-Book (P/B) ratio in mrq is 2.50. Its current Enterprise Value per Revenue stands at 2.303 whereas that against EBITDA is 12.017.
Stock Price History:
Over the past 52 weeks, DGX has reached a high of $159.36, while it has fallen to a 52-week low of $120.10. The 50-Day Moving Average of the stock is -2.13%, while the 200-Day Moving Average is calculated to be 7.04%.
Shares Statistics:
For the past three months, DGX has traded an average of 808.44K shares per day and 636010 over the past ten days. A total of 111.00M shares are outstanding, with a floating share count of 110.77M. Insiders hold about 0.49% of the company’s shares, while institutions hold 89.60% stake in the company. Shares short for DGX as of 1726185600 were 2418663 with a Short Ratio of 2.99, compared to 1723680000 on 2790365. Therefore, it implies a Short% of Shares Outstanding of 2418663 and a Short% of Float of 2.48.
Dividends & Splits
According to the company, the forward annual dividend rate for DGX is 2.96, from 2.92 in the trailing year. Against a Trailing Annual Dividend Yield of 0.019626295The stock’s 5-year Average Dividend Yield is 1.91.
